Non-interventional, prospective, multicenter study to evaluate treatment satisfaction, treatment preference, quality of life, and tolerability under treatment with Briumvi® for relapsing forms of multiple sclerosis (RMS) with active disease in daily clinical practice

Authors
Category Primary study
Registry of TrialsGerman Clinical Trials Register
Year 2024
This article has no abstract
Epistemonikos ID: 43847daa34248b7d1846a0f331b68539e0a748db
First added on: Apr 10, 2025